IPO registrations (S-1, F-1) · Registrants

ACTUATE THERAPEUTICS, INC.

SEC CIK
1652935 · filings on EDGAR ↗
Registration
Form S-1, first filed 2024-05-24, last 2026-10-19; 4 initial registrations, 7 amendments
Outcome
Final prospectus filed 2024-08-13; declared effective 2024-08-12
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1751 RIVER RUN, SUITE 400, Fort Worth, TX 76107
EIN
47-3044785
Ticker
ACTU (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
ACTUATE THERAPEUTICS, INC. on the corporate pages

Offering terms

Proposed price range
$8.00–$10.00 per share (S-1/A filed 2024-07-23)
Final price
$8.00 per share, within the range (424B4 filed 2024-08-13, an initial public offering)
Shares sold
2,800,000
Gross proceeds
$22,400,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ACTU
Lead underwriters
Titan Partners
Syndicate
American Capital Partners; Newbridge Securities Corporation

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 17

FiledFormWhat it isName as filedEDGAR
2024-05-24S-1S-1 (registration)ACTUATE THERAPEUTICS, INC.0001104659-24-065172 ↗
2024-06-11S-1/AS-1/A (amendment)ACTUATE THERAPEUTICS, INC.0001104659-24-070185 ↗
2024-06-21S-1/AS-1/A (amendment)ACTUATE THERAPEUTICS, INC.0001104659-24-073848 ↗
2024-07-16S-1/AS-1/A (amendment)ACTUATE THERAPEUTICS, INC.0001104659-24-080179 ↗
2024-07-19S-1/AS-1/A (amendment)ACTUATE THERAPEUTICS, INC.0001104659-24-081008 ↗
2024-07-23S-1/AS-1/A (amendment)ACTUATE THERAPEUTICS, INC.0001104659-24-081626 ↗
2024-08-12EFFECTEFFECT (declared effective)ACTUATE THERAPEUTICS, INC.9999999995-24-002495 ↗
2024-08-13424B4424B4 (final prospectus)ACTUATE THERAPEUTICS, INC.0001104659-24-088877 ↗
2025-03-28S-1S-1 (registration)ACTUATE THERAPEUTICS, INC.0001683168-25-001948 ↗
2025-04-16EFFECTEFFECT (declared effective)ACTUATE THERAPEUTICS, INC.9999999995-25-001131 ↗
2025-07-25S-1S-1 (registration)ACTUATE THERAPEUTICS, INC.0001683168-25-005402 ↗
2025-08-04EFFECTEFFECT (declared effective)ACTUATE THERAPEUTICS, INC.9999999995-25-002471 ↗
2025-09-08EFFECTEFFECT (declared effective)ACTUATE THERAPEUTICS, INC.9999999995-25-002878 ↗
2026-10-06S-1S-1 (registration)ACTUATE THERAPEUTICS, INC.0001683168-26-007661 ↗
2026-10-14S-1/AS-1/A (amendment)ACTUATE THERAPEUTICS, INC.0001683168-26-007832 ↗
2026-10-19S-1/AS-1/A (amendment)ACTUATE THERAPEUTICS, INC.0001683168-26-007941 ↗
2026-10-26EFFECTEFFECT (declared effective)ACTUATE THERAPEUTICS, INC.9999999995-26-003345 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2024-07-23S-1/Aregistration statement$8.00–$10.00$9.002,950,000$26,550,000Nasdaq ACTU3primary document; range, price sentence, shares headline, proceeds computed, cover names 3document ↗
2024-08-13424B4final prospectus$8.002,800,000$22,400,000Nasdaq ACTU3primary document; price sentence, shares headline, proceeds table, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Bios Actuate Co-Invest III, LPDirector,TenPercentOwner52024–2025
BIOS Actuate Co-Invest II, LPDirector,TenPercentOwner52024–2025
BIOS Actuate Co-Invest I, LPDirector,TenPercentOwner52024–2025
BIOS Advisors GP, LLCDirector,TenPercentOwner52024–2025
BIOS Capital Management, LPDirector,TenPercentOwner52024–2025
Bios Clinical Opportunity Fund, LPDirector,TenPercentOwner; TenPercentOwner52024–2025
Bios Equity COF, LPDirector,TenPercentOwner; TenPercentOwner52024–2025
BIOS Equity Partners III, LPDirector,TenPercentOwner52024–2025
Bios Equity Partners II, LPDirector,TenPercentOwner; TenPercentOwner52024–2025
Bios Equity Partners, LPDirector,TenPercentOwner; TenPercentOwner52024–2025
BIOS Fund III, LPDirector,TenPercentOwner52024–2025
BIOS Fund III NT, LPDirector,TenPercentOwner52024–2025
BIOS Fund III QP, LPDirector,TenPercentOwner52024–2025
BIOS Fund II, LPDirector,TenPercentOwner; TenPercentOwner52024–2025
BIOS Fund II NT, LPDirector,TenPercentOwner; TenPercentOwner52024–2025
BIOS Fund II QP, LPDirector,TenPercentOwner; TenPercentOwner52024–2025
BIOS Fund I, LPDirector,TenPercentOwner; TenPercentOwner52024–2025
BIOS Fund I QP, LPDirector,TenPercentOwner; TenPercentOwner52024–2025
BP Directors, LPDirector,TenPercentOwner; TenPercentOwner52024–2025
Cavu Advisors, LLCDirector,TenPercentOwner; TenPercentOwner52024–2025
Cavu Management, LPDirector,TenPercentOwner; TenPercentOwner52024–2025
Fletcher Aaron G.L.Director,TenPercentOwner72024–2026
Kairos-Actuate SPV, L.P.Director,Other22024
Kairos SPV Fund LLCDirector,Other22024
Kairos Venture Opportunities I, L.P.Director,Other22024
Kairos Venture Partners II, L.P.Director,Other; Director,TenPercentOwner32024–2026
Keyes Jason ADirector42024–2026
Kreis Leslie W.Director,TenPercentOwner; TenPercentOwner52024–2025
LYTLE PAUL JOfficerChief Financial Officer42024–2026
Mazar Andrew PaulOfficerChief Operating Officer32024–2026
SCHMITT DANIEL MDirector,OfficerPresident, CEO and Director62024–2026
THOMSON TODD SDirector,Other; Director,TenPercentOwner52024–2026
Zabrowski DanDirector42024–2026
Bios 2024 Co-Invest, LPDirector,Other; Director,TenPercentOwner22024–2025
RONNEBERG AMY LDirector42024–2026
Sawhney RogerDirector42024–2026
Huber Martin H. Jr.Director22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2025-07-07ACTUATE THERAPEUTICS, INC.Pharmaceuticals$9,330,958$4,665,47981
2025-04-10ACTUATE THERAPEUTICS, INC.Pharmaceuticals$50,000,000$011
2024-03-06ACTUATE THERAPEUTICS, INC.Pharmaceuticals$5,000,000$3,000,00011
2022-10-19ACTUATE THERAPEUTICS, INC.Pharmaceuticals$50,000,000$19,336,491952
2020-12-10ACTUATE THERAPEUTICS, INC.Pharmaceuticals$50,000,000$14,482,301141
2019-10-15ACTUATE THERAPEUTICS, INC.Pharmaceuticals$6,500,000$6,500,000172
2019-05-13ACTUATE THERAPEUTICS, INC.Pharmaceuticals$23,952,152$21,886,833211
2018-09-12ACTUATE THERAPEUTICS, INC.Pharmaceuticals$4,025,000$4,025,000181
2017-03-20ACTUATE THERAPEUTICS, INC.Pharmaceuticals$5,000,000$3,000,00021
2017-02-03ACTUATE THERAPEUTICS, INC.Pharmaceuticals$150,000$150,00011
2015-10-08ACTUATE THERAPEUTICS, INC.Pharmaceuticals$500,000$410,00041

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationACTUATE THERAPEUTICS, INC.TXState business registriesname and state
Form D issuerACTUATE THERAPEUTICS, INC.TXForm D private offeringsCIK (EXACT)
Patent assigneeACTUATE THERAPEUTICS INC.TXPatents (USPTO)name and state
SEC filerACTUATE THERAPEUTICS, INC.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerActuate Therapeutics, Inc.TXTrademarks (USPTO)name and state

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, TX first:

More with this interest.

In other datasets, the same topic (Health) in TX:

Interests: Pharmaceutical Preparations · Health